With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

More potent DAPT strategies and oral anticoagulation were tied to worse outcomes and should be avoided, researchers say.

The essential thrombocythemia market is on a growth trajectory, driven by increasing diagnosis rates, aging population ...

the anticoagulant drug warfarin and its analogs, and the antiplatelet agent clopidogrel. Cite this: Realities and Expectations of Pharmacogenomics and Personalized Medicine: Impact of Translating ...

The novel oral anticoagulants are cost-effective alternatives to warfarin therapy. Oral antiplatelets Patients with polymorphisms associated with clopidogrel nonresponse are generally successful ...

Anticoagulants interact with the proteins responsible for ... It is commercially available as a tablet in nine different strengths. Clopidogrel, known by its brand name, Plavix, is classified as a ...

This study is the first multicentre, randomised, non-inferiority comparative study of dual antiplatelet therapy (DAPT) and direct oral anticoagulant (DOAC ... the DAPT group will be given aspirin 100 ...

If we ate a varied, healthy diet and were outdoors regularly, supplementation would be limited to those with a proven need.

In a statement, the FDA noted that this generic approval “will make a direct impact on American patients who rely on anticoagulant medications.” It is unclear when the generics will be available.